Anticarcinogenic impact of interferon therapy on the propression of hepatocellular carcinoma in patients with chronic viral infection
スポンサーリンク
概要
- 論文の詳細を見る
- 2012-01-01
著者
-
Nishiguchi Shuhei
Division Of Hepatobiliary And Pancreatic Disease Department Of Internal Medicine Hyogo College Of Me
-
SHIMOMURA Soji
Division of Hepatobiliary and Pancreatic disease, Department of Internal Medicine, Hyogo College of Medicine
関連論文
- The efficacy of ursodeoxycholic acid and bezafibrate combination therapy for primary biliary cirrhosis : A prospective, multicenter study
- Crucial role of impaired Kupffer cell phagocytosis on the decreased Sonazoid-enhanced echogenicity in a liver of a nonalchoholic steatohepatitis rat model
- Overweight and obesity increase the risk for liver cancer in patients with liver cirrhosis and long-term oral supplementation with branched-chain amino acid granules inhibits liver carcinogenesis in heavier patients with liver cirrhosis
- Involvement of hepatoma-derived growth factor in the growth inhibition of hepatocellular carcinoma cells by vitamin K_2
- Vitamin K2 inhibits the proliferation of HepG2 cells by up-regulating the transcription of p21 gene
- Chemoprevention of spontaneous development of hepatocellular carcinomas in fatty liver Shionogi mice by a cyclooxygenase-2 inhibitor
- Effects of lamivudine on outcome after liver resection for hepatocellular carcinoma in patients with active replication of hepatitis B virus
- Coffee consumption and reduced risk of hepatocellular carcinoma among patients with chronic type C liver disease : A case-control study
- Does alcohol increase the risk of hepatocellular carcinoma among patients with hepatitis C virus infection?
- TRENDS IN THE CAUSES AND OUTCOME OF LIVER CIRRHOSIS DIAGNOSED BY LAPAROSCOPY IN OSAKA, JAPAN DURING THE PAST THREE DECADES
- Lack of mitochondrial DNA enhances growth of hepatocellular carcinoma in vitro and in vivo
- Potential role of vitamin K_2 as a chemopreventive agent against hepatocellular carcinoma
- Detection of serum hepatitis B virus DNA by real-time quantitative polymerase chain reaction (TaqMan PCR) during lamivudine treatment : comparison with three other assays
- Influence of interferon therapy on outcome after surgery for hepatitis C virus-related hepatocellular carcinoma
- Etiology of liver cirrhosis in Japan : a nationwide survey
- A New Epitope of CYP2D6 Recognized by Liver Kidney Microsomal Autoantibody from Japanese Patients with Autoimmune Hepatitis(Pharmacology)
- Vitamin K2 downregulates the expression of fibroblast growth factor receptor 3 in human hepatocellular carcinoma cells
- Hepatoma-derived growth factor is induced in liver regeneration
- Clinical Characteristics of Patients who Developed Hepatocellular Carcinoma after Hepatitis C Virus Eradication with Interferon Therapy: Current Status in Japan
- Combination of hepatitis B viral antigens and DNA for prediction of relapse after discontinuation of nucleos(t)ide analogs in patients with chronic hepatitis B
- Guideline on the use of new anticancer drugs for the treatment of Hepatocellular Carcinoma 2010 update
- Guidelines on nutritional management in Japanese patients with liver cirrhosis from the perspective of preventing hepatocellular carcinoma
- Anticarcinogenic impact of interferon therapy on the propression of hepatocellular carcinoma in patients with chronic viral infection
- Serum zinc value in patients with hepatitis virus-related chronic liver disease: association with the histological degree of liver fibrosis and with the severity of varices in compensated cirrhosis
- Nutritional status and quality of life in current patients with liver cirrhosis as assessed in 2007-2011